Natco Pharma Limited has announced the successful completion of the delisting of Adcock Ingram Holdings Limited, one of South Africa’s oldest pharmaceutical companies, from the Johannesburg Stock Exchange (JSE). This event marks the culmination of a strategic acquisition in which NATCO Pharma has acquired 35.75% of Adcock Ingram in a transaction valued at approximately USD 226 million (ZAR 4 billion). In July 2025, Natco Pharma offered ZAR 75 (US$ 4.36) per share to acquire Adcock Ingram's minority shareholders, a proposal that was approved in October 2025 with thumping support from the shareholders. With the completion of this acquisition of stake, Natco Pharma attains market presence in South Africa.

" Natco Pharma aims to leverage Adcock Ingram’s established market posit

See Full Page